Anavex Life Sciences Corp (AVXL)

[frrol]

The nightmare scenario is that ADCS reduction didn't get met, which means the company misled the public. The shareholder class action suits will start flying, share price will really plummet. It wouldn't be that big a nightmare; the company would argue in public and in court that odds-ratio is a valid clinical outcome gauge, and would likely get the suits dismissed. Far before that, we'd be getting the PDD OLE results, and eventually the Excellence results. And the full AD data, which would help us design the Phase 3.

But Missling's credibility and reputation would be shot, and the market would really punish the stock for a while. Regardless, we have plenty of cash. And that's thanks to Missling btw.

But let's see what Missling does with the TLR "follow up". Hopefully it doesn't get whiffed like CTAD or the Monday call. We've already got 2 strikes here. Bases are loaded.